Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Entolimod by Statera Biopharma for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome): Likelihood of Approval
Entolimod is under clinical development by Statera Biopharma and currently in Phase I for Radiation Toxicity (Radiation Sickness, Acute Radiation...